ABC | Volume 111, Nº2, Agosto 2018

Posicionamento 1º Posicionamento Brasileiro sobre o Impacto dos Distúrbios de Sono nas Doenças Cardiovasculares da Sociedade Brasileira de Cardiologia Arq Bras Cardiol. 2018; 111(2):290-340 136. deOliveira AC, Martinez D, Massierer D, Gus M, Gonçalves SC, Ghizzoni F, et al. The antihypertensive effect of positive airway pressure on resistant hypertension of patients with obstructive sleep apnea: a randomized, double-blind,clinicaltrial.Am JRespirCritCareMed.2014;190(3):345-7. doi: 10.1164/rccm.201403-0479LE. 137. MuxfeldtES,MargalloV,CostaLM,GuimarãesG,CavalcanteAH,Azevedo JC, et al. Effects of continuous positive airway pressure treatment on clinic and ambulatory blood pressures in patients with obstructive sleep apnea and resistant hypertension: a randomized controlled trial. Hypertension. 2015;65(4):736-42. doi: 10.1161/HYPERTENSIONAHA. 138. Iftikhar IH, Valentine CW, Bittencourt LR, CohenDL, Fedson AC, Gíslason T, et al. Effects of continuous positive airway pressure on blood pressure in patients with resistant hypertension and obstructive sleep apnea: a meta-analysis. J Hypertens. 2014;32(12):2341-50. doi: 10.1097/ HJH.0000000000000372. 139. Martinez-Garcia MA, Capote F, Campos-Rodriguez F, Lloberes P, Díaz de Atauri MJ, Somoza M, et al; Spanish Sleep Network. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA. 2013;310(22):2407-15. doi: 10.1001/jama.2013.281250. 140. Liu L, Cao Q, Guo Z, Dai Q. Continuous positive airway pressure in patients with obstructive sleep apnea and resistant hypertension: a meta- analysis of randomized controlled trials. J Clin Hypertens (Greenwich). 2016;18(2):153-8. doi: 10.1111/jch.12639. 141. Sánchez-de-la-Torre M, Khalyfa A, Sánchez-de-la-Torre A, Martinez- AlonsoM, Martinez-GarcíaMA, Barceló A, et al; Spanish Sleep Network. Precisionmedicine in patients with resistant hypertension and obstructive sleep apnea: blood pressure response to continuous positive airway pressure treatment. J Am Coll Cardiol. 2015;66(9):1023-32. doi: 10.1016/j.jacc.2015.06.1315. 142. BrattonDJ,GaislT,WonsAM,KohlerM.CPAPvsmandibularadvancement devices and blood pressure in patients with obstructive sleep apnea: a systematic review andmeta-analysis. JAMA. 2015;314(21):2280-93. doi: 10.1001/jama.2015.16303. 143. Gagnadoux F, Pépin JL, Vielle B, Bironneau V, Chouet-Girard F, Launois S, et al. Impact of mandibular advancement therapy on endothelial function in severe obstructive sleep apnea. Am J Respir Crit Care Med. 2017;195(9):1244-1252. doi: 10.1164/rccm.201609-1817OC. 144. Issa FG. Effect of clonidine in obstructive sleep apnea. AmRev Respir Dis. 1992;145(2 Pt 1):435-9. doi: 10.1164/ajrccm/145.2_Pt_1.435. 145. Kraiczi H, Hedner J, Peker Y, Grote L. Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea. Am J Respir Crit Care Med. 2000;161(5):1423-8. doi: 10.1164/ajrccm.161.5.9909024. 146. Pépin JL, Tamisier R, Barone-Rochette G, Launois SH, Levy P, Baguet JP. Comparison of continuous positive airway pressure and valsartan in hypertensive patients with sleep apnea. Am J Respir Crit Care Med. 2010;182(7):954-60. doi: 10.1164/rccm.200912-1803OC. 147. White LH, Bradley TD, Logan AG. Pathogenesis of obstructive sleep apnoea in hypertensive patients: role of fluid retention and nocturnal rostral fluid shift. J Hum Hypertens. 2015;29(6):342-50. doi: 10.1038/ jhh.2014.94. 148. Witkowski A, Prejbisz A, Florczak E, Kadziela J, Sliwinski P, Bielen P, et al. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension. 2011;58(4):559-65. doi: 10.1161/ HYPERTENSIONAHA.111.173799. 149. Kario K, Bhatt DL, Kandzari DE, Brar S, Flack JM, Gilbert C, et al. Impact of renal denervation on patients with obstructive sleep apnea and resistant hypertension: insights from the SYMPLICITY HTN-3 Trial. Circ J. 2016;80(6):1404-12. doi: 10.1253 /circj.CJ- 16-0035. 150. Bhatt DL, Kandzari DE, O’Neill WW, D’Agostino R, Flack JM, Katzen BT, et al; SYMPLICITY HTN-3 Investigators. A controlled trial of renal denervation for resistant hypertension. NEngl J Med. 2014;370(15):1393- 401. doi: 10.1056/NEJMoa1402670. 151. Guilleminault C, Connolly SJ, Winkle RA. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome Am J Cardiol. 1983;52(5):490-4. PMID: 6193700. 152. Cintra FD, Leite RP, Storti LJ, Bittencourt LA, Poyares D, Castro LD, et al. Sleep apnea and nocturnal cardiac arrhythmia: a populational study. Arq Bras Cardiol. 2014;103(5):368-74. doi: http://dx.doi.org/10.5935/ abc.20140142 153. Oliveira W, Campos O, Bezerra Lira-Filho E, Cintra FD, Vieira M, Ponchirolli A, et al. Left atrial volume and function in patients with obstructive sleep apnea assessed by real-time three-dimensional echocardiography. J Am Soc Echocardiogr. 2008;21(12):1355-61. doi: 10.1016/j.echo.2008.09.007. 154. DragerLF,BortolottoLA,PedrosaRP,KriegerEM,Lorenzi-FilhoG.Leftatrial diameter is independently associatedwith arterial stiffness in patients with obstructive sleep apnea: potential implications for atrial fibrillation. Int J Cardiol. 2010;144(2):257-9. doi: 10.1016/j.ijcard.2009.01.018. 155. Gami AS, Pressman G, Caples SM, Kanagala R, Gard JJ, Davison DE, et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation. 2004;110(4):364-7. doi: 10.1161/01.CIR.0000136587.68725.8E. 156. KanagalaR,MuraliNS,FriedmanPA,AmmashNM,GershBJ,BallmanKV,et al.Obstructive sleepapneaandrecurrenceofatrial fibrillation.Circulation. 2003;107(20):2589-94. doi: 10.1161/01.CIR.0000068337.25994.21. 157. Fein AS, Shvilkin A, Shah D, Haffajee CI, Das S, Kumar K, et al. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol. 2013;62(4):300-5. doi: 10.1016/j.jacc.2013.03.052. 158. Ng CY, Liu T, Shehata M, Stevens S, Chugh SS, Wang X. Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation. Am J Cardiol. 2011;108(1):47-51. doi: 10.1016/j. amjcard.2011.02.343. 159. Koehler U, Fus E, Grimm W, Pankow W, Schafer H, Stammnitz A, et al. Heartblock inpatientswithobstructivesleepapnoea:pathogenetic factors and effects of treatment. Eur Respir J. 1998;11(2):434-9. PMID: 9551750. 160. Somers VK, Dyken ME, Mark AL, Abboud FM. Parasympathetic hyperresponsiveness and bradyarrhythmias during apnoea in hypertension. Clin Auton Res. 1992;2(3):171-6. PMID: 1498563. 161. Grimm W, Hoffmann J, Menz V, Kohler U, Heitmann J, Peter JH, et al. Electrophysiologic evaluation of sinus node function and atrioventricular conduction in patients with prolonged ventricular asystole during obstructive sleep apnea. Am J Cardiol. 1996;77(15):1310-4. PMID: 8677871. 162. Koehler U, Becker HF, Grimm W, Heitmann J, Peter JH, Schafer H. Relations among hypoxemia, sleep stage, and bradyarrhythmia during obstructive sleep apnea. Am Heart J. 2000;139(1 Pt 1):142-8. PMID: 10618575. 163. Roche F, Xuong AN, Court-Fortune I, Costes F, Pichot V, Duverney D, et al. Relationship among the severity of sleep apnea syndrome, cardiac arrhythmias, and autonomic imbalance. Pacing Clin Electrophysiol. 2003;26(3):669-77. PMID: 12698666. 164. Mehra R, Benjamin EJ, Shahar E, GottliebDJ, Nawabit R, Kirchner HL, et al. Association of nocturnal arrhythmias with sleep-disordered breathing: The SleepHeart Health Study. Am J Respir Crit CareMed. 2006;173(8):910-6. doi: 10.1164/rccm.200509-1442OC. 165. Abe H, Takahashi M, Yaegashi H, Eda S, Tsunemoto H, Kamikozawa M, et al. Efficacy of continuous positive airway pressure on arrhythmias in obstructive sleep apnea patients. Heart Vessels. 2010;25(1):63-9. doi: 10.1007/s00380-009-1164-z. 166. Gami AS, Olson EJ, Shen WK, Wright RS, Ballman KV, Hodge DO, et al. Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults. J AmColl Cardiol. 2013;62(7):610-6. doi: 10.1016/j.jacc.2013.04.080. 329